# An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/an-enhanced-international-prognostic-index-nccn-ipi-for-patients-with-diffuse/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zheng Zhou,Laurie H. Sehn,Alfred Rademaker,Leo I. Gordon,Ann S. LaCasce,Allison Crosby‐Thompson,Ann Vanderplas,Andrew D. Zelenetz,Gregory A. Abel,Maria Alma Rodriguez,Auayporn Nademanee,Mark Kaminski,Myron S. Czuczman,Michael Millenson,Joyce C. Niland,Randy D. Gascoyne,Joseph M. Connors,Jonathan W. Friedberg,Jane N. Winter |
| Citations | 959 |
| DOI | 10.1182/blood-2013-09-524108 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2063691874 |
| PMID | 24264230 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Gregory A. Abel](https://scholariq.org/researchers/gregory-a-abel/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Paper topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.